Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 22

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 22
---
 other associates; |

| • |     | reviews and discusses with management the Company’s compensation plans and policies for all employees (including the Named Executive Officers) with respect to risk management and risk-inducing incentives; |

| • |     | ensures preparation of the Compensation Discussion and Analysis and the Compensation Committee Report as required by SEC regulations; |

| • |     | monitors compliance of executive officers and non-employee directors with relevant stock ownership guidelines; |

| • |     | reviews with management periodically, as it deems appropriate, management succession and inclusion and diversity practices; |

| • |     | administers our Executive Management Incentive Compensation Plan and other substantially similar or successor incentive compensation plans; and |

| • |     | annually evaluates its performance. |

Scope of Authority, Processes and Procedures The Organization & Compensation Committee acts on behalf of the Board of Directors to establish the compensation of our executive officers and provides oversight of our compensation philosophy, as described in this proxy statement under the caption “Compensation Discussion and Analysis.” The role of the executive officers and the outside compensation consultant in establishing executive compensation is discussed in this proxy statement under the caption “Compensation Discussion and Analysis.” Other than routine administrative matters and the ability of our CEO to approve grants of equity awards subject to certain individual and annual thresholds, no executive compensation decisions are delegated to management.

| Corporate Governance • 2025 Proxy Statement | Humana |     | 27 |

Compensation Committee Interlocks and Insider Participation No member of the Organization & Compensation Committee: (i) is or has ever been an officer or employee of the Company; or (ii) is or was, during the last fiscal year, a participant in a “related person” transaction requiring disclosure under Item 404 of the SEC’s regulations (see discussion in this proxy statement under the caption “Certain Transactions with Management and Others”); or (iii) is an executive officer of another entity at which one of our executive officers serves either as a director or on its compensation committee. Corporate Governance Determinations During 2024, Wayne A. I. Frederick, M.D. (Chair), Karen W. Katz, and Brad D. Smith served as members of our Organization & Compensation Committee. Considering (i) the source of each director’s compensation, including any consulting, advisory or other compensatory fees paid by the Company; and (ii) whether each director has an affiliate relationship with the Company, a subsidiary of the Company or an affiliate of a subsidiary of the Company, the Board has